Topics

Pancreatic Cancer Drug, Alone and In Combination Shows Early Promise

20:00 EDT 10 Oct 2019 | Cancer Networks

Treatment with 9-ING-41 significantly increased pancreatic tumor cell killing when combined with chemotherapy in pre-clinical trials.

Original Article: Pancreatic Cancer Drug, Alone and In Combination Shows Early Promise

NEXT ARTICLE

More From BioPortfolio on "Pancreatic Cancer Drug, Alone and In Combination Shows Early Promise"

Quick Search

Relevant Topics

Pancreatic Cancer
The pancreas secretes a number of important hormones into the digestive tract and the blood stream. Cancers are most commonly exocrine than endocrine (neuroendocrine) tumors. Functional tumors secrete hormones; Insulinoma, Gastrinoma, Somatostatinoma, VI...

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...